PT Kalbe Farma Tbk
La empresa farmacéutica y de suplementos para la salud que cotiza en bolsa más grande del sudeste asiático.
PT Kalbe Farma Tbk es la empresa farmacéutica y de salud del consumidor que cotiza en bolsa más grande de Indonesia y del sudeste asiático y produce medicamentos recetados, medicamentos de venta libre, suplementos nutricionales y productos funcionales para la salud con marcas que incluyen Extra Joss, Fitbar, Diabetasol y Prenagen. Kalbe International gestiona las exportaciones y el comercio transfronterizo del grupo en el sudeste asiático y África, con instalaciones establecidas en Nigeria para atender los mercados africanos. La compañía se asocia activamente con distribuidores mayoristas para sus líneas de suplementos nutricionales y de salud para el consumidor en toda la ASEAN y más allá.
- Type
- brand seeking distribution
- Location
- Jakarta, Indonesia
- Founded
- 1966
- Website
- kalbe.co.id
- Categories
- Suplementos y bienestar, Suministros médicos y sanitarios
- Markets
- Malasia, Singapur, Vietnam, Tailandia, Filipinas, Nigeria, Sudáfrica
Verified facts
- product-authorised-for-sale (green), checked 2026-08-19 BPOM (Indonesian Food and Drug Authority), public register of products authorised for sale in Indonesia (Cek Produk)
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- web-presence-since (green), checked 2026-08-08 Internet Archive (Wayback)
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- facility-registered (green), checked 2026-08-19 BPOM (Indonesian Food and Drug Authority), public register of manufacturing facilities behind product registrations (Sarana)
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)